Using immunoperoxidase staining method, a human monoclonal antibody (MAb), termed HB4C5, which was generated by fusion of NAT-30 cells with regional lymph node lymphocytes from a lung cancer patient, was examined for tumor specificity. The determinant recognized by HB4C5 MAb was well preserved in us
Diagnostic application of a monoclonal antibody against small cell lung cancer
โ Scribed by Pieter E. Postmus; Tineke J. W. Hirschler-Schulte; Loe De Leij; Sibrand Poppema; Job E. Elema; Enje T. H. Edens; Geert Mesander; Henk J. Sluiter; T. Hauw
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 406 KB
- Volume
- 57
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The purpose of this investigation was to determine the targeting potential of the murine monoclonal antibody (MAb) RNL-I for human small-cell lung cancer (SCLC) in a nude mouse model. RNL-I is preferentially reactive with SCLC and lung carcinoids, and was classified as a cluster-I MAb as defined by
The intact anti-SCLC monoclonal antibody (MAb) SEN7 and its F(ab'), were labelled with the P-emitting isotope 67Cu. Both materials retained their biological activity in vitro as determined by the Lindmo assay. In a direct comparison of in vivo distribution in a xenograph model, l3Il-and 67Cu-labelle
The cellular nuclear antigen SS-B/La is known to be a major antigenic target to an autoantibody in patients with Sjogren's syndrome and systemic lupus erythematosus. It is useful to detect an anti-SS-B/La antibody from patients' sera in a clinical point of view. We purified SS-B/La from rabbit thymu
We have previously described the tumor-asrocisited sialoglycoprotein antigen sGP,,,, defined by the murine LAME MAb. The antigen is characterized by strong memlbrane expression in a proportion of small-cell carcinomas of the lung, but little or no expression on normal tissues of epithelial or neural
The ability of monoclonal antibody (mAb) alR-3 to interact with non-small cell lung cancer (NSCLC) cells was investigated. MAb alR-3 inhibited specific binding of 1251-IGF-I and 1251-alR-3 to a panel of 8 NSCLC cell lines with high affinity (IC50 = 200 and 50 ng/ml, respectively). 1251-alR-3 bound w